Home›Stocks›FDMT

FDMT — structural market context

4D Molecular Therapeutics, Inc

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $12.62 (Oct 21) vs $13.10 (Oct 20): −3.66%.

Volume

1.90× its 20-session average (1.1M) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 11.2M shares (settlement Sep 30) vs 12.0M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 2 days with fails, largest 50K shares on Sep 18.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 1 day with fails, largest 6 shares on Sep 10.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

FDMT short interest & days to cover

SHARES SHORT
11.2M
% OF FLOAT
26.4%
DAYS TO COVER
9.3
CHANGE VS PRIOR
-6.4%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

FDMT fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-24 · 28d17K$15
2026-09-18 · 34d50K$14.68
2026-09-10 · 42d6$14.18

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

FDMT insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 10 sales

InsiderTypeSharesValueFiled
Bizily Scott · officer: Chief Legal OfficerSale (S)2K$21K2026-10-20
Kirn David · director, officer: See RemarksSale (S)272$4K2026-10-07
Kirn David · director, officer: See RemarksSale (S)58K$750K2026-10-07
Bizily Scott · officer: Chief Legal OfficerSale (S)2K$22K2026-09-22
Kirn David · director, officer: See RemarksSale (S)58K$811K2026-09-16

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

FDMT analyst ratings

FirmActionRatingPublished
B.Riley Financialprice_target—2026-10-01
Bank of America SecuritiesholdBuy2026-09-29
Cantor FitzgeraldupgradeOverweight (from Neutral)2026-09-14
Cantor Fitzgeraldprice_target—2026-09-14
B. RileyholdBuy2026-08-17

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is FDMT's short interest?
As of the FINRA settlement date 2026-09-30, FDMT had 11.2M shares sold short — 26.4% of its float, with 9.3 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying FDMT?
In the last 12 months of SEC Form 4 filings, FDMT recorded 0 insider purchases and 10 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about FDMT?
The most recent action: B.Riley Financial price_target on 2026-10-01. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell FDMT?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with F

FERG · Ferguson Enterprises Inc.FFIN · First Financial Bankshares, InFHN · First Horizon CorporationFICO · Fair Isaac CorporationFIS · Fidelity National InformationFISV · Fiserv, Inc.All F →

FDMT: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.